Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.32 USD | -0.90% | -0.61% | +3.96% |
23/04 | Morgan Stanley Adjusts Exelon's Price Target to $38 From $37, Keeps Equalweight Rating | MT |
22/04 | Scotiabank Adjusts Exelon's Price Target to $37 From $39 | MT |
Sales 2024 * | 21.49B 1,792B | Sales 2025 * | 22B 1,835B | Capitalization | 37.31B 3,111B |
---|---|---|---|---|---|
Net income 2024 * | 2.45B 204B | Net income 2025 * | 2.64B 220B | EV / Sales 2024 * | 3.88 x |
Net Debt 2024 * | 46.02B 3,837B | Net Debt 2025 * | 48.82B 4,071B | EV / Sales 2025 * | 3.91 x |
P/E ratio 2024 * |
15.2
x | P/E ratio 2025 * |
14.2
x | Employees | 19,962 |
Yield 2024 * |
4.09% | Yield 2025 * |
4.34% | Free-Float | 99.67% |
Latest transcript on Exelon Corporation
1 day | -0.90% | ||
1 week | -0.61% | ||
Current month | -0.67% | ||
1 month | +2.08% | ||
3 months | +6.60% | ||
6 months | -4.67% | ||
Current year | +3.96% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.58% | 1 M€ | -.--% | - | |
2.45% | 610 M€ | -1.18% | ||
1.56% | 18 M€ | +3.79% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 37.32 | -0.90% | 5,439,450 |
25/24/25 | 37.66 | -0.29% | 3,958,519 |
24/24/24 | 37.77 | +0.56% | 5,061,364 |
23/24/23 | 37.56 | -0.29% | 5,700,331 |
22/24/22 | 37.67 | +0.32% | 5,174,426 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.96% | 37.31B | |
+8.64% | 136B | |
+4.41% | 80.06B | |
-2.19% | 77.98B | |
+0.69% | 75.38B | |
-8.92% | 66.47B | |
+61.15% | 59.36B | |
+4.97% | 44.9B | |
+7.34% | 42.26B | |
0.00% | 41.94B |
- Stock Market
- Equities
- EXC Stock